Literature DB >> 11259841

Adenovirus-mediated gene transfer to liver.

J M Wilson1.   

Abstract

Mesh：

Year:  2001        PMID： 11259841     DOI： 10.1016/s0169-409x(00)00125-3

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


× No keyword cloud information.
  9 in total

1.  Absence of direct delivery for single transmembrane apical proteins or their "Secretory" forms in polarized hepatic cells.

Authors:  M Bastaki; L T Braiterman; D C Johns; Y-H Chen; A L Hubbard
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

2.  Optimizing vector application for gene transfer into human hepatoblastoma cells.

Authors:  Steven W Warmann; Sorin Armeanu; Heike Heitmann; Peter Ruck; Guido Seitz; Johannes T Wessels; Marie-Luise Lemken; Ulrich M Lauer; Jörg Fuchs; Michael Bitzer
Journal:  Pediatr Surg Int       Date:  2006-07-29       Impact factor: 1.827

3.  In vitro gene targeting in human hepatoblastoma.

Authors:  Steven W Warmann; Sorin Armeanu; Heike Frank; Heike Buck; Florian Graepler; Marie-Luise Lemken; Heike Heitmann; Guido Seitz; Ulrich M Lauer; Michael Bitzer; Jörg Fuchs
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

4.  Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus.

Authors:  Matteo Iannacone; Giovanni Sitia; Iñigo Narvaiza; Zaverio M Ruggeri; Luca G Guidotti
Journal:  Clin Vaccine Immunol       Date:  2007-09-19

5.  Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.

Authors:  Wai Han Yiu; Chi-Jiunn Pan; Paul A Mead; Matthew F Starost; Brian C Mansfield; Janice Y Chou
Journal:  J Hepatol       Date:  2009-02-05       Impact factor: 25.083

6.  Platelets mediate cytotoxic T lymphocyte-induced liver damage.

Authors:  Matteo Iannacone; Giovanni Sitia; Masanori Isogawa; Patrizia Marchese; Maria G Castro; Pedro R Lowenstein; Francis V Chisari; Zaverio M Ruggeri; Luca G Guidotti
Journal:  Nat Med       Date:  2005-10-30       Impact factor: 53.440

Review 7.  Gene therapy for type I glycogen storage diseases.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Curr Gene Ther       Date:  2007-04       Impact factor: 4.391

Review 8.  Recombinant AAV-directed gene therapy for type I glycogen storage diseases.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Expert Opin Biol Ther       Date:  2011-04-20       Impact factor: 4.388

9.  Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.

Authors:  W H Yiu; C-J Pan; M Allamarvdasht; S Y Kim; J Y Chou
Journal:  Gene Ther       Date:  2006-09-28       Impact factor: 5.250
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.